Skip to content

Effect to the health condition by the nutrition guidance in consideration of the amino acid levels in phase 3 cardiac rehabilitation - randomised controlled trial -

Effect to the health condition by the nutrition guidance in consideration of the amino acid levels in phase 3 cardiac rehabilitation - Effect to the health condition by the nutrition guidance in consideration of the amino acid levels in phase 3 cardiac rehabilitation - randomised controlled trial -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044069
Enrollment
20
Registered
2021-05-01
Start date
2021-02-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease

Interventions

nutrition education/one year Normal treatment

Sponsors

Juntendo University Cardiovascular Biology and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients of phase 3 cardiac rehabilitation

Exclusion criteria

Exclusion criteria: 1.Chronic kidney disease on hemodialysis, severe liver disease. 2.The person who takes an amino acid-based supplement

Design outcomes

Primary

MeasureTime frame
Readmission for the cardiovascular diseases one year after the nutrition education initiation

Secondary

MeasureTime frame
Anaerobic threshold healthy QOL

Countries

Japan

Contacts

Public ContactKosuke Fukao

Juntendo University Cardiovascular Biology and Medicine

fukao777@juntendo.ac.jp+81338133111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026